NCT05260489

Brief Summary

The purpose of this study is to examine how Transcutaneous Vibratory Stimulation (TVS) produced by the Apollo wearable affects sleep and cardiovascular function in a diverse real-world population of Apollo users.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2022

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

February 10, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 2, 2022

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

July 9, 2024

Status Verified

July 1, 2024

Enrollment Period

3.5 years

First QC Date

February 10, 2022

Last Update Submit

July 8, 2024

Conditions

Keywords

sleep quality, HRV, tvs, wearable

Outcome Measures

Primary Outcomes (10)

  • Average Heart Rate during sleep

    The average heart rate measured during sleep in beats per minute

    Through study completion, an average of 4 years

  • Heart Rate Variability during sleep

    The Heart Rate Variability value measured during sleep in milli seconds

    Through study completion, an average of 4 years

  • Lowest Heart Rate during sleep

    The lowest Heart Rate measured during sleep in beats per minutes

    Through study completion, an average of 4 years

  • Sleep Onset

    The amount of time it takes to fall asleep once you are on the bed in seconds

    Through study completion, an average of 4 years

  • Sleep efficiency

    The proportion of time spent sleeping to total time in bed

    Through study completion, an average of 4 years

  • Wake time during sleep

    Total amount of time spent awake during a sleep session in seconds

    Through study completion, an average of 4 years

  • Sleep duration

    Total amount of time spent sleeping in seconds

    Through study completion, an average of 4 years

  • Deep sleep duration

    Total amount of time spent in deep sleep during sleep sessions in seconds

    Through study completion, an average of 4 years

  • REM sleep duration

    Total amount of time spent in REM sleep during sleep sessions in seconds

    Through study completion, an average of 4 years

  • Pittsburgh Sleep Quality Index (PSQI)

    The Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. With a range of scores 1-21.

    Through study completion, an average of 4 years

Secondary Outcomes (1)

  • Oura Sleep Score

    Through study completion, an average of 4 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Current Apollo Neuro customers who own and use Oura ring devices

You may qualify if:

  • Aged 18 or more
  • Use both the Apollo wearable and Oura ring

You may not qualify if:

  • Inability to complete questionnaires written in English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Apollo Neuroscience, Inc.

Pittsburgh, Pennsylvania, 15219, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • David Rabin, MD PHD

    Apollo Neuroscience, Inc.

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2022

First Posted

March 2, 2022

Study Start

January 18, 2022

Primary Completion

August 1, 2025

Study Completion

October 1, 2025

Last Updated

July 9, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations